Log In
Print
BCIQ
Print
Print this Print this
 

ribavarin elaidate (TRX-201) (formerly CP-4033)

  Manage Alerts
Collapse Summary General Information
Company Weifa ASA
DescriptionLipid Vector Technology (LVT) derivative of ribavirin which inhibits eukaryotic translation initiation factor 4E (eIF4E)
Molecular Target Eukaryotic translation initiation factor 4E (eIF4E)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationThyroid cancer
Indication DetailsTreat aggressive thyroid cancer; Treat thyroid cancer
Regulatory Designation

U.S. - Orphan Drug (Treat thyroid cancer)

Partner

Translational Therapeutics Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today